AR044492A1 - Metodos de deteccion de la enfermedad de alzheimer - Google Patents

Metodos de deteccion de la enfermedad de alzheimer

Info

Publication number
AR044492A1
AR044492A1 ARP040101994A ARP040101994A AR044492A1 AR 044492 A1 AR044492 A1 AR 044492A1 AR P040101994 A ARP040101994 A AR P040101994A AR P040101994 A ARP040101994 A AR P040101994A AR 044492 A1 AR044492 A1 AR 044492A1
Authority
AR
Argentina
Prior art keywords
polymorphism
lines
indifferent
minor allele
disease
Prior art date
Application number
ARP040101994A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR044492A1 publication Critical patent/AR044492A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos de diagnóstico o pronóstico de la enfermedad de Alzheimer en un sujeto. Dicho método comprende al menos una etapa de detección de la presencia o la ausencia del alelo minoritario del polimorfismo rs908832 del gen ABCA2. La presencia del alelo minoritario del polimorfismo rs908832 del gen ABCA2 indica que el sujeto puede padecer la enfermedad de Alzheimer o bien presentar un riesgo aumentado de desarrollar la enfermedad de Alzheimer. Reivindicación 15: Cebo, que permite la amplificación del alelo minoritario del polimorfismo rs908832. Reivindicación 21: Sonda según la reivindicación 20, caracterizada porque presenta la secuencia SEQ ID Nº 8. Reivindicación 27: Animales transgénicos, líneas de tejidos indiferentes y líneas celulares diferenciales a partir de estas líneas de tejidos indiferentes, en el genoma de las cuales está insertada al menos una secuencia de ADN exógeno genómico que porta el alelo minoritario del polimorfismo rs908832 del gen ABCA2. Reivindicación 29: Procedimiento de obtención de animales transgénicos, líneas de tejidos indiferentes y líneas de células diferenciadas a partir de estas líneas de tejidos indiferentes, según una de las reivindicaciones 27 y 28, caracterizado porque comprende la generación de animales transgénicos, de líneas de tejidos indiferentes y de líneas de células diferenciadas a partir de estas líneas de tejidos indiferentes, que comprenden el alelo minoritario del polimorfismo rs908832 del gen ABCA2 humano. Reivindicación 31: Célula extraída de animales transgénicos, como se describe en una de las reivindicaciones 27 y 28.
ARP040101994A 2003-06-20 2004-06-09 Metodos de deteccion de la enfermedad de alzheimer AR044492A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0307501A FR2856409B1 (fr) 2003-06-20 2003-06-20 Methodes de detection de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
AR044492A1 true AR044492A1 (es) 2005-09-14

Family

ID=33484616

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101994A AR044492A1 (es) 2003-06-20 2004-06-09 Metodos de deteccion de la enfermedad de alzheimer

Country Status (25)

Country Link
EP (1) EP1639139B1 (es)
JP (1) JP4691491B2 (es)
KR (1) KR101170651B1 (es)
CN (1) CN1809645B (es)
AR (1) AR044492A1 (es)
AT (1) ATE518005T1 (es)
AU (1) AU2004249919B2 (es)
BR (1) BRPI0411658A (es)
CA (1) CA2529633C (es)
CY (1) CY1111970T1 (es)
DK (1) DK1639139T3 (es)
ES (1) ES2370491T3 (es)
FR (1) FR2856409B1 (es)
HK (1) HK1090392A1 (es)
HR (1) HRP20110778T1 (es)
IL (1) IL172690A0 (es)
MX (1) MXPA05012800A (es)
NO (1) NO20060257L (es)
PL (1) PL1639139T3 (es)
PT (1) PT1639139E (es)
RU (2) RU2483108C2 (es)
SI (1) SI1639139T1 (es)
TW (1) TWI352738B (es)
WO (1) WO2004113568A2 (es)
ZA (1) ZA200509945B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103013989A (zh) * 2011-09-23 2013-04-03 深圳北京大学香港科技大学医学中心 与老年痴呆症发病相关的细胞周期依赖性激酶5的单核苷酸多态性位点
GB201212084D0 (en) * 2012-07-06 2012-08-22 Randox Lab Ltd Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
CN102768189B (zh) * 2012-07-30 2014-11-19 黄石 一种药物筛选方法
CN104313144B (zh) * 2014-10-16 2017-02-01 卫生部北京医院 一种检测阿尔茨海默病易感性的试剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853995A (en) * 1997-01-07 1998-12-29 Research Development Foundation Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6
EP1210422A2 (en) * 1999-08-20 2002-06-05 Active Pass Pharmaceuticals, Inc. Human abc2 transporter and uses thereof
AU7699501A (en) * 2000-07-20 2002-02-05 Cephalon Inc Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
JP2004147502A (ja) * 2000-07-26 2004-05-27 Banyu Pharmaceut Co Ltd ヒト及びラットabca2遺伝子
WO2002064781A2 (en) * 2001-02-09 2002-08-22 Active Pass Pharmaceuticals, Inc. Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
AU2002304931A1 (en) * 2001-06-08 2002-12-23 University Of British Columbia Methods for treating disorders of the nervous and reproductive systems

Also Published As

Publication number Publication date
FR2856409A1 (fr) 2004-12-24
FR2856409B1 (fr) 2007-08-31
KR20060029232A (ko) 2006-04-05
KR101170651B1 (ko) 2012-08-03
CN1809645A (zh) 2006-07-26
DK1639139T3 (da) 2011-11-21
RU2380423C2 (ru) 2010-01-27
EP1639139B1 (fr) 2011-07-27
CA2529633C (fr) 2014-08-05
PL1639139T3 (pl) 2011-12-30
CA2529633A1 (fr) 2004-12-29
AU2004249919B2 (en) 2009-08-13
IL172690A0 (en) 2006-04-10
WO2004113568A2 (fr) 2004-12-29
SI1639139T1 (sl) 2011-11-30
JP2007515151A (ja) 2007-06-14
NO20060257L (no) 2006-01-18
CY1111970T1 (el) 2015-11-04
TWI352738B (en) 2011-11-21
MXPA05012800A (es) 2006-05-17
PT1639139E (pt) 2011-10-24
WO2004113568A3 (fr) 2005-05-06
RU2483108C2 (ru) 2013-05-27
BRPI0411658A (pt) 2006-08-08
JP4691491B2 (ja) 2011-06-01
ZA200509945B (en) 2007-03-28
HRP20110778T1 (hr) 2011-11-30
CN1809645B (zh) 2013-11-20
RU2006101561A (ru) 2006-06-10
RU2009104533A (ru) 2010-08-20
ATE518005T1 (de) 2011-08-15
HK1090392A1 (en) 2006-12-22
ES2370491T3 (es) 2011-12-16
TW200517502A (en) 2005-06-01
EP1639139A2 (fr) 2006-03-29
AU2004249919A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
Zhang et al. DNA methylation and heterochromatinization in the male-specific region of the primitive Y chromosome of papaya
Tanaka et al. Genetic architecture and functional characterization of genes underlying the rapid diversification of male external genitalia between Drosophila simulans and Drosophila mauritiana
Carneiro et al. Methods and tools currently used for the identification of plant parasitic nematodes
DE602005009324D1 (de) Methode zur Krebsdiagnose mittels Nachweis von DNA und RNA im Kreislauf
WO2004075733A3 (en) Construction of a deafness gene chip
HK1150634A1 (en) Methods and materials using signaling probes
AR051673A1 (es) Loci geneticos asociados con tolerancia a sclerotinia en soja
ATE461294T1 (de) Brustkrebsdiagnoseverfahren
ATE535618T1 (de) Spezifisches verfahren zum nachweis von prostatakrebs auf grundlage des pca3-gens sowie kits dafür
ES2687251T3 (es) Biomarcador de cáncer circulante y su uso
AR044492A1 (es) Metodos de deteccion de la enfermedad de alzheimer
Nourani et al. CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector
JP7007710B2 (ja) クロマグロの遺伝的性判別マーカーおよび遺伝的性判別方法
DE60303706D1 (de) Mausmodell für Leberzellkarzinom durch zielgerichtete Integration von Hepatitis B Virus Genen
Li et al. Quantitative field testing Heterodera glycines from metagenomic DNA samples isolated directly from soil under agronomic production
CN107119119A (zh) Deletion片段及其在检测苹果属植物矮化中的应用
JP5716217B2 (ja) 長鎖繰返し配列を含有する遺伝子又は遺伝子産物の選択又は優先的回収方法
JP2011120558A5 (es)
Jasinska Biological Resources for Genomic Investigation in the Vervet Monkey (Chlorocebus)
KR20120050058A (ko) Wmv-cp 형질전환 수박의 정성 분석방법
JP4347609B2 (ja) 膀胱癌検査キット
Henterly et al. Comparison of morphological versus molecular characters for discriminating between sympatric meadow and prairie voles
KR20160116922A (ko) 돼지생식기호흡기증후군바이러스 저항성 개체 판별용 조성물
CN101633936B (zh) 一种鱼类转基因育种的方法
CN108841922A (zh) 一种筛选动物抗病育种的方法

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration